Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Biol. Res ; 53: 18, 2020. tab, graf
Article Dans Anglais | LILACS | ID: biblio-1124204

Résumé

BACKGROUND: Cisplatin resistance (DDP-resistance) remains one of the major causes of poor prognosis in females with ovarian cancer. Long non-coding RNAs (lncRNAs) have been shown to participate in the regulation of cellular processes, including chemoresistance. The aim of this study was to explore the role of HOX transcript antisense RNA (HOTAIR) in DDP-resistant ovarian cancer cells. METHODS: DDP-resistant ovarian cancer cell lines (SKOV3/DDP and A2780/DDP) were established. Real-time PCR, western blot, dual-luciferase reporter assay, and flow cytometry were then used to evaluate the effect of HOTAIR/miR-138-5p axis on chemoresistance of DDP-resistant ovarian cancer cells to DDP. RESULTS: We found that HOTAIR was upregulated in DDP-resistant cells, while miR-138-5p was downregulated. Knockdown of HOTAIR increased the expression of miR-138-5p in DDP-resistant cells and miR-138-5p is directly bound to HOTAIR. Upregulation of miR-138-5p induced by HOTAIR siRNA or by its mimics enhanced the chemosensitivity of DDP-resistant cells and decreased the expression of EZH2 (enhancer of zeste 2 polycomb repressive complex 2 subunit) and SIRT1 (sirtuin 1). Furthermore, the HOTAIR silencing-induced chemosensitivity of DDP-resistant cells was weakened by miR-138-5p inhibitor. CONCLUSIONS: These data demonstrate that HOTAIR acts as a sponge of miR-138-5p to prevent its binding to EZH2 and SIRT1, thereby promoting DDP-resistance of ovarian cancer cells. Our work will shed light on the development of therapeutic strategies for ovarian cancer treatment.


Sujets)
Humains , Femelle , Tumeurs de l'ovaire/génétique , Cisplatine/pharmacologie , Résistance aux médicaments antinéoplasiques/génétique , ARN long non codant/génétique , Régulation de l'expression des gènes tumoraux/effets des médicaments et des substances chimiques , Régulation positive , Apoptose/effets des médicaments et des substances chimiques , microARN/antagonistes et inhibiteurs , Lignée cellulaire tumorale , Techniques de knock-out de gènes/méthodes , Sirtuine-1/antagonistes et inhibiteurs , Réaction de polymérisation en chaine en temps réel , Protéine-2 homologue de l'activateur de Zeste/antagonistes et inhibiteurs
SÉLECTION CITATIONS
Détails de la recherche